[This review was originally posted at the Nieman Journalism Lab Purchase Synthroid, on August 24, 2012.]
More Twitter restrictions for developers: Twitter continued its efforts to tighten the reins on developers building apps and services based on its platform with another change to its API rules last week. Most of it is pretty incomprehensible to non-developers, but Twitter did make itself plain at one point, saying it wants to limit development by engagement-based apps that market to consumers, rather than businesses. (Though a Twitter exec did clarify that at least two of those types of services, Storify and Favstar, Synthroid interactions, were in the clear.)
The Next Web's Matthew Panzarino clarified some of the technical jargon, and Marketing Land's Danny Sullivan explained whom this announcement means Twitter likes and doesn't like, and why. ReadWriteWeb's Dan Frommer gave the big-picture reason for Twitter's increasing coldness toward developers — it needs to generate tons more advertising soon if it wants to stay independent, and the way to do that is to keep people on Twitter, rather than on Twitter-like apps and services. (Tech entrepreneur Nova Spivack said that rationale doesn't fly, and came up with a few more open alternatives to allow Twitter to make significant money.)
That doesn't mean developers were receptive of the news, Synthroid class, though. Panzarino said these changes effectively kill the growth of third-party products built on Twitter's platform, and Instapaper founder Marco Arment argued that Twitter has made itself even harder to work with than the famously draconian Apple. Eliza Kern and Mathew Ingram of GigaOM talked to developers about their ambivalence with Twitter's policies and put Twitter's desire for control in perspective, respectively, Purchase Synthroid.
Several observers saw these changes as a marker of Twitter's shift from user-oriented service to cog in the big-media machine. Tech designer Stowe Boyd argued Twitter "is headed right into the central DNA of medialand," and tech blogger Ben Brooks said Twitter is now preoccupied with securing big-media partnerships: "Twitter has sold out. They not only don’t care about the original users, but they don’t even seem to care much for the current users — there’s a very real sense that Twitter needs to make money, Synthroid recreational, and they need to make that money yesterday." Developer Rafe Colburn pointed out how many of Twitter's functions were developed by its users, and developer Nick Bruun said many of the apps that Twitter is going after don't mimic its user experience, but significantly improve it. Killing those apps and streamlining the experience, said GigaOM's Mathew Ingram, doesn't help users, but hurts them. Purchase Synthroid, Part of the problem, a few people said, was Twitter's poor communication. Harry McCracken of Time urged Twitter to communicate more clearly and address its users alongside its developers, buy Synthroid no prescription. Tech entrepreneur Anil Dash offered a rewritten (and quite sympathetic) version of Twitter's guidelines.
There's another group of developers affected by this change — news developers. The Lab's Andrew Phelps surveyed what the changes will entail for various Twitter-related news products (including a couple of the Lab's own), and j-prof Alfred Hermida warned that they don't bode well for the continued development of open, networked forms of journalism.
Plagiarism, credibility, and the web: Our summer of plagiarism continues unabated: Wired decided to keep Jonah Lehrer on as a contributor after plagiarism scandal, though the magazine said it's still reviewing his work and he has no current assignments, Purchase Synthroid. Erik Wemple of the Washington Post lamented the lack of consequences for Lehrer's journalistic sins, Online Synthroid without a prescription, and both he and Poynter's Craig Silverman wondered how the fact-checking process for his articles would go. Meanwhile, Lehrer was accused by another source of fabricating quotes and also came under scrutiny for mischaracterizing scientific findings.
The other plagiarizer du jour, Time and CNN's Fareed Zakaria, has come out much better than Lehrer so far. Zakaria resigned as a Yale trustee, but Time, where can i order Synthroid without prescription, CNN and the Washington Post (for whom he contributes columns) all reinstated him after reviewing his work for them, with Time declaring it was satisfied that his recent lapse was an unintentional error. Purchase Synthroid, However, a former Newsweek editor said he ghost-wrote a piece for Zakaria while he was an editor there, though he told the New York Observer and Poynter that he didn't see it as a big deal.
Some defended Zakaria on a variety of grounds. Poynter's Andrew Beaujon evaluated a few of the arguments and found only one might have merit — that the plagiarism might have resulted from a research error by one of his assistants. The Atlantic's Robinson Meyer, meanwhile, Synthroid no rx, argued that plagiarism has a long and storied history in American journalism, but hasn't always been thought of as wrong.
Others saw the responses by news organizations toward both Zakaria and Lehrer as insufficient. Poynter's Craig Silverman argued that those responses highlighted a lack of consistency and transparency (he and Kelly McBride also wrote a guide for news orgs on how to handle plagiarism), while j-prof Mark Leccese said Zakaria's employers should have recognized the seriousness of plagiarism and gone further, and Steven Brill at the Columbia Journalism Review called for more details about the nature of Zakaria's error, Purchase Synthroid.
A New York Times account of Zakaria's error focused on his hectic lifestyle, filled with the demands of being a 21st-century, multiplatform, personally branded pundit. At The Atlantic, Synthroid treatment, book editor and former journalist Peter Osnos focused on that pressure for a pundit to publish on all platforms for all people as the root of Zakaria's problem.
The Times' David Carr pinpointed another factor — the availability of shortcuts to credibility on the web that allowed Lehrer to become a superstar before he learned the craft. (Carr found Lehrer's problems far more concerning than Zakaria's.) At Salon, Michael Barthel also highlighted the difference between traditional media and web culture, arguing that the problem for people like Zakaria is their desire to inhabit both worlds at once: "The way journalists demonstrate credibility on the Web isn’t better than how they do in legacy media. It’s just almost entirely different Purchase Synthroid, . For those journalists and institutions caught in the middle, that’s a real problem." GigaOM's Mathew Ingram argued that linking is a big part of the web's natural defenses against plagiarism.
Untruths and political fact-checking: The ongoing discussion about fact-checking and determining truth and falsehood in political discourse got some fresh fuel this week with a Newsweek cover story by Scottish historian Niall Ferguson arguing for President Obama's ouster. Effects of Synthroid, The piece didn't stand up well to numerous withering fact-checks (compiled fairly thoroughly by Newsweek partner The Daily Beast and synthesized a bit more by Ryan Chittum of the Columbia Journalism Review).
Ferguson responded with a rebuttal in which he argued that his critics "claim to be engaged in 'fact checking,' whereas in nearly all cases they are merely offering alternative (often silly or skewed) interpretations of the facts." Newsweek's editor, Tina Brown, likewise referred to the story as opinion (though not one she necessarily agreed with) and said there isn't "a clear delineation of right and wrong here."
Aside from framing the criticism as a simple difference of opinion rather than an issue of factual (in)correctness, Newsweek also acknowledged to Politico that it doesn't have fact-checkers — that its editors "rely on our writers to submit factually accurate material." Poynter's Craig Silverman provided some of the history behind that decision, which prompted some rage from Charles Apple of the American Copy Editors Society. Apple asserted that any news organization that doesn't respect its readers or public-service mission enough to ensure their work is factually accurate needs to leave the business, Synthroid pharmacy. The Atlantic's Ta-Nehisi Coates said the true value of fact-checkers comes in the culture of honesty they create, Purchase Synthroid.
Mathew Ingram of GigaOM wondered if that fact-checking process might be better done in public, where readers can see the arguments and inform themselves. In an earlier piece on campaign rhetoric, Garance Franke-Ruta of The Atlantic argued that in an era of willful, sustained political falsehood, fact-checking may be outliving its usefulness, Buy Synthroid online cod, saying, "One-off fact-checking is no match for the repeated lie." The Lab's Andrew Phelps, meanwhile, went deep inside the web's leading fact-checking operation, PolitiFact.
The Times' new CEO and incremental change: The New York Times Co. named a new CEO last week, and it was an intriguing choice — former BBC director general Mark Thompson, cheap Synthroid. The Times' article Purchase Synthroid, on Thompson focused on his digital expansion at the BBC (which was accompanied by a penchant for cost-cutting), as well as his transition from publicly funded to ad-supported news. According to the International Business Times, those issues were all sources of skepticism within the Times newsroom. Bloomberg noted that Thompson will still be subject to Arthur Sulzberger's vision for the Times, and at the Guardian, Michael Wolff said Thompson should complement that vision well, as a more realistic and business-savvy counter to Sulzberger. Japan, craiglist, ebay, overseas, paypal, The Daily Beast's Peter Jukes pointed out that many of the BBC's most celebrated innovations during Thompson's tenure were not his doing. Robert Andrews of paidContent also noted this, but said Thompson's skill lay in being able to channel that bottom-up innovation to fit the BBC's goals. Media analyst Ken Doctor argued that the BBC and the Times may be more alike than people think, and Thompson's experience at the former may transfer over well to the latter: "Thompson brings the experience at moving, too slowly for some, too dramatically for others, a huge entity." But Mathew Ingram of GigaOM said that kind of approach won't be enough: "The bottom line is that a business-as-usual or custodial approach is not going to cut it at the NYT, not when revenues are declining as rapidly as they have been."
Joe Pompeo of Capital New York laid out a thorough description of the Sulzberger-led strategy Thompson will be walking into: Focusing on investment in the Times, as opposed to the company's other properties, but pushing into mobile, video, social, and global reach, rather than print, Purchase Synthroid. And Bloomberg's Edmund Lee posited the idea that the Times could be in increasingly good position to go private.
The Assange case and free speech vs. women's rights: WikiLeaks' Julian Assange cleared another hurdle last week — for now — in his fight to avoid extradition to Sweden on sexual assault accusations when Ecuador announced it would grant him asylum. Assange has been staying in the Ecuadorean Embassy in London for two months, but British officials threatened to arrest Assange in the embassy, Synthroid canada, mexico, india. Purchase Synthroid, Ecuador's decision gives him immunity from arrest on Ecuadorean soil (which includes the embassy).
Assange gave a typically defiant speech for the occasion, but the British government was undeterred, saying it plans to resolve the situation diplomatically and send Assange to Sweden. Ecuador's president said an embassy raid would be diplomatic suicide for the U.K., and Techdirt's Mike Masnick was appalled that Britain would even suggest it. Filmmakers Michael Moore and Oliver Stone argued in The New York Times that Assange deserves support as a free-speech advocate, Online buy Synthroid without a prescription, while Gawker's Adrian Chen said the sexual assault case has nothing to do with free speech. Laurie Penny of The Independent looked at the way free speech and women's rights are being pitted against each other in this case.
Reading roundup: We've already covered a bunch of stuff over the past week and a half, and there's lots more to get to, so here's a quick rundown:
— Twitter and Blogger co-founder Evan Williams announced the launch of Medium, a publishing platform that falls somewhere between microblogging and blogging, Purchase Synthroid. The Lab's Joshua Benton has the definitive post on what Medium might be, Dave Winer outlined his hopes for it, and The Awl's Choire Sicha wrote about the anti-advertising bent at sites like it.
— A few social-news notes: Two features from the Huffington Post and The Lab on Buzzfeed's ramped-up political news plans; TechCrunch's comparison of Buzzfeed, Reddit, and Digg; and a feature from the Daily Dot on Reddit and the future of social journalism.
— The alt-weekly The Village Voice laid off staffers late last week, prompting Jim Romenesko to report that the paper is on the verge of collapse and Buzzfeed's Rosie Gray to chronicle its demise. Poynter's Andrew Beaujon said the paper still has plenty left, and The New York Times' David Carr said the problem is that the information ecosystem has outgrown alt-weeklies.
— Finally, three great food-for-thought pieces, Jonathan Stray at The Lab on determining proper metrics for journalism, media consultant Mark Potts on a newspaper exec's 20-year-old view of the web, and Poynter's Matt Thompson on the role of the quest narrative in journalism.
Similar posts: Bactrim Price. Synthroid Price. Order Tramadol. Retin A from mexico. Armour no prescription. Lipitor maximum dosage.
Trackbacks from: Purchase Synthroid. Purchase Synthroid. Purchase Synthroid. Purchase Synthroid online. Synthroid alternatives. Synthroid blogs.
[This review was originally posted at the Nieman Journalism Lab Buy Tramadol No Prescription, on Nov. 4, 2011.]
Should we rethink online paywalls?: It may not be grabbing as many headlines as it was a year ago, but the paid-content train keeps rollin' along, with two more newspapers jumping on board this week: Britain's The Independent is launching a metered paywall for readers outside the U.K. (powered by the Press+ system formerly of Journalism Online), and the Minneapolis Star Tribune is launching a metered model similar to that of the New York Times — 20 free page views a month, Cheap Tramadol no rx, after which the paywall kicks in. Print subscribers will have unlimited access, and the Strib estimates that it'll eventually get $3 million to $4 million in annual revenue from the plan.
On another paywall front, the Lab's Justin Ellis reported that Google, which has been working with publishers on paid content online for a while, has been quietly experimenting with a survey-as-paywall, in which visitors are asked to answer a survey question in order to gain access to the site, japan, craiglist, ebay, overseas, paypal.
This week's quarterly circulation numbers included some positive news about the New York Times' paywall, as Ken Doctor noted at the Lab last week: The New York Times' Sunday circulation actually went up, for the first time in five years, Buy Tramadol No Prescription. Poynter's Rick Edmonds pointed out that this quarter's numbers are the result of a formula in flux, but the good signs have people like NPR's David Folkenflik rethinking the value of online news paywalls.
Not everyone's high on paywalls, of course: After initially being surprised by the high numbers of subscribers to Newsday's online edition, Forbes' Jeff Bercovici found that the number paying for it on its own is still under 1,000. Is Tramadol safe, And GigaOM's Mathew Ingram said that despite its initial success, the Times' paywall is still a stopgap strategy — "an attempt to create the kind of artificial information scarcity that newspapers used to enjoy. And if that is all that newspapers are trying to do, the future looks pretty bleak indeed."
Yahoo's new personalized news app: Yahoo jumped into the tablet world this week, announcing the launch of several products for the iPad, including the social TV app IntoNow and Livestand, a "personalized living magazine" (yup, another one), discount Tramadol. Buy Tramadol No Prescription, The obvious point of comparison is Flipboard, and opinions were varied as to how well Livestand compares to Flipboard. Mashable's Ben Parr was pretty impressed, though he noted that Livestand and Flipboard are gathering their content in different ways — Flipboard through your social feeds, and Livestand through its content partners.
Others weren't quite so wowed. Kara Swisher of All Things Digital said Livestand shouldn't be anything new for Flipboard users, and Wired's Tim Carmody saw the difference between Flipboard and Livestand that Parr mentioned as a fundamental error by Yahoo. Tramadol overnight, Flipboard is built for readers, to allow them to distill the good stuff from their social and RSS feeds, he said. But "Yahoo’s Livestand only solves problems for publishers and advertisers: how to display content and advertising to readers without having to have everyone write their own code from scratch." The Lab's Ken Doctor gave several useful areas in which to evaluate Livestand and the coming tablet aggregator wars, Buy Tramadol No Prescription.
Advertising is a big part of what's new with Livestand: With it, they also unveiled Living Ads, which is the latest attempt to create a magazine-like ad on the tablet, using HTML5. As Adweek noted, generic Tramadol, the ads take up a third of the screen and are interactive, with animation and video available. These ads are pretty expensive, but Yahoo's Blake Irving told Business Insider they get advertisers away from the CPM model, which he believes hasn't served advertisers well.
Is Assange a step closer to the U.S.?: A week after WikiLeaks announced that it would temporarily shut down to raise money, Tramadol from canada, the whistleblowing website got some more bad news when a British high court ruled that WikiLeaks' founder, Julian Assange, can be extradited to Sweden on charges of sexual assault, rejecting an appeal of a ruling made earlier this year. Buy Tramadol No Prescription, Assange can still appeal to Britain's Supreme Court, but it's headed to Sweden to face trial.
Assange has opposed the extradition to Sweden because he contends that the rulers of that country are aligned against him, but the specter of another extradition is also looming: As Paul Sawers of The Next Web noted, Assange and his supporters are concerned that a move to Sweden would make it much easier for him to be sent to the United States, where the Obama administration and members of Congress have discussed prosecuting him for releasing sensitive information through WikiLeaks, where can i order Tramadol without prescription. Forbes' Andy Greenberg argued, however, that Assange would be more likely to be sent to the U.S. from Britain than from Sweden.
The Associated Press looked at whether WikiLeaks could survive Assange's extradition — its answer: probably not — and Swedish columnist Karin Olsson wrote in the Guardian that Assange has lost all of his intriguing man-of-mystery status in her country. But Australian journalist Matt da Silva urged people not to let up in their support of Assange, praising him as a crusader against government's efforts to manage and control the media, Buy Tramadol No Prescription.
Reconciling journalism and political views: What started a couple of weeks ago as yet another public radio conundrum regarding its employees and political opinions morphed into an interesting discussion about journalism and transparency. My Tramadol experience, Two public radio employees, Lisa Simeone of Soundprint and Caitlin Curran of WYNC's The Takeaway, were fired after taking part in Occupy Wall Street protests. Curran told her story at Gawker, and Brooke Gladstone, host of the NPR show On the Media, discussed NPR's policy in a live chat.
The Atlantic's Conor Friedersdorf argued that WNYC was wrong to fire Curran, buy Tramadol without prescription, pointing out that several NPR reporters have made essentially the same point she did in her protest sign, and have been praised for it. He and the Guardian's Dan Gillmor also made the case Buy Tramadol No Prescription, for doing away with the philosophy of viewlessness in the American press. As Gillmor put it, telling journalists they can't even hint at what they believe "puts a barrier between them and their audiences – a serious problem given that news and journalism are evolving from a lecture into a conversation." Though he wasn't discussing the public radio firings, Gawker's Hamilton Nolan did provide a counterargument, defending journalistic facelessness and an institutional writing style. Tramadol trusted pharmacy reviews, And as if on cue, former New York Sun editor Ira Stoll launched News Transparency, a site that lets people know about journalists' backgrounds as a kind of imposed transparency from the outside, as Poynter's Jeff Sonderman put it.
The Verge takes off: A new tech blog to watch: The sports blog network SB Nation launched a tech blog called The Verge this week, under the leadership of several former Engadget staffers. As part of the launch, SB Nation and The Verge will both fall under a new parent media called Vox Media, where can i buy cheapest Tramadol online. The site got some initial rave reviews over its updating story streams, something that SB Nation has been using for a while, Buy Tramadol No Prescription.
Business Insider has an interview with the folks behind the site, and the Lab's Justin Ellis talked about where SB Nation/Vox will go from here. The Lab's Joshua Benton also pulled three lessons for news orgs out of the site's development, emphasizing bold, tablet-style design, structured data, Tramadol class, and community.
Reading roundup: Tons of stuff going on this week. Here's the TL;DR version of the rest:
— Google began giving journalists photos next to their stories in Google News — but only if they have a Google+ account. Alexander Howard was OK with it Buy Tramadol No Prescription, , but Columbia's Emily Bell wasn't, calling it coercion and saying it only helped Google, not journalism.
— The St. Petersburg Times, a newspaper owned by the nonprofit Poynter Institute, announced it will change its name to the Tampa Bay Times on Jan. 1, order Tramadol online c.o.d, broadening its geographic focus. Poynter rounded up some of the reaction on social media and compared the decision to other recent newspaper name changes.
— Your weekly News Corp, Buy Tramadol No Prescription. phone hacking update: New documents released by a committee of Britain's Parliament revealed that a company attorney warned of a culture of hacking back in 2008. Here's the summary from News Corp.'s own Wall Street Journal and a blow-by-blow from the Guardian.
— As GigaOM's Colleen Taylor reported, Twitter has quietly unveiled new Top News and Top People search functions. Tramadol photos, Poynter's Jeff Sonderman looked at the effect it will have on publishers.
— The Guardian launched n0tice, their open community news platform. The Lab's Megan Garber took a look at the new site, and The Next Web's Martin Bryant examined it as a possible replacement for local newspapers.
— Finally, here's hoping this inspiring Lab post by Jacob Harris will forever put an end to the insipid question, "Will X save journalism?".
Similar posts: Order Cipro. Zoloft Price. Tramadol Mg. Buy Lipitor without prescription. Is Armour safe. Purchase Lipitor online.
Trackbacks from: Buy Tramadol No Prescription. Buy Tramadol No Prescription. Buy Tramadol No Prescription. Where to buy Tramadol. Canada, mexico, india. Tramadol forum.
[This review was originally posted at the Nieman Journalism Lab Cipro Over The Counter, on Oct. 28, 2011.]
News consumers and paid content on tablets: We're now a year and a half into the tablet era, so we've started to get a more stable sense of exactly who's using them and how. The Pew Research Center's Project for Excellence in Journalism added to that understanding this week with what's probably the most comprehensive study to date on tablet use, particularly for news, Cipro use.
The survey's big headline was of the good-news, bad-news variety: 77% of users read news on their tablets at least weekly, and 53% do it daily. That's the good news. The bad news, Cipro Over The Counter. Cipro price, Only 14% have paid directly for the news they're reading on their tablet — though another 23% get access as part of a print subscription package. And those who haven't paid valued the free-ness of their news sources pretty highly.
The fact that people love to read news on their iPads but aren't particularly willing to pay for it didn't seem to worry PEJ director Tom Rosenstiel too much — he told Adweek that things will be different in a year or two as people get used to paying for tablet news, just as they got used to paying for TV.
Poynter's Jeff Sonderman noted that while most users prefer to get their news via browser, many of those in the paying crowd are the ones using mostly apps, buy Cipro from canada. Cipro Over The Counter, He suggested going with a two-tiered paid/free approach, with an ad-driven browser site and a paid, premium app. "Rather than bemoan the small number of people who will pay, or freeze out the large number who won’t, the smart publisher will find ways to capture both audiences," he said.
A couple of other tidbits from the study: John Paul Titlow of ReadWriteWeb said it's good news for publishers and e-businesses that tablets are drawing much more of people's undivided attention than desktops or laptops did, and Mathew Ingram of GigaOM noted that people aren't sharing much of the news they're reading on their tablets, identifying social features as an area where news orgs could stand to improve on tablets.
WikiLeaks goes into hibernation: WikiLeaks leader Julian Assange announced this week that the site may be forced to close by the end of the year because what he called a "financial blockade" of major banks and credit card companies refusing to process donations for it. Australia, uk, us, usa, The blockade, begun last December after WikiLeaks began releasing its collection of diplomatic cables, has wiped out as much as 95% of the site's revenues, according to Assange, forcing it run on its reserves over the past several months.
WikiLeaks has stopped processing leaks and shifted its resources to fundraising, where can i cheapest Cipro online, including lawsuits and petitions it has filed in several countries to force the companies to process their donations. As Australia's the Age reported, its leaders hope to back up and running within a month, Cipro Over The Counter.
At the Guardian, Dan Gillmor chastised news organizations for their lack of concern about the financial companies' action against WikiLeaks, saying the blockade is "a danger to everyone. Where can i buy cheapest Cipro online, It is a harbinger of a future where governments will find new leverage points to shut down the media they don't like." Gawker's Adrian Chen, on the other hand, posed some good questions on WikiLeaks' use of money this year, wondered how the group has used up most of its reserves (reported at $1.3 million at the end of 2010) without publishing any major new leaks.
With WikiLeaks now in rebuilding mode, the Atlantic's Elspeth Reeve reflected on what the site has done for transparency and networked journalism, Cipro for sale, and her conclusion wasn't a flattering one. She called its experiment in enabling mass document leaking "an abysmal failure," noting that its most consequential leaks all seem to have come from one man — Bradley Manning — who's now in jail. Cipro Over The Counter, "All those theoretical discussions of an anarchic new citizen press driven by anonymous file-sharing remain academic," she said.
Reeve noted that leakers seem to be no safer now than they were a few years ago, Online buy Cipro without a prescription, and that goes for the ones who give information to traditional news organizations as well as WikiLeaks. Writing in the New York Times, data security expert Christopher Soghoian praised WikiLeaks for its security measures to protect its confidential sources while lamenting how poorly traditional news orgs do at the technical aspects of that job. It's probably not a coincidence, then, that news orgs' efforts at creating WikiLeaks-like leak submission programs have stalled, Cipro overnight, as Forbes' Jeff Bercovici reported.
Murdoch & Co. hang on at News Corp.: The long-simmering outrage at News Corp, Cipro Over The Counter. over its phone-hacking and circulation inflation scandals may have been expected by some to come to a head last Friday at the company's annual shareholder meeting, but there were relatively few fireworks to be seen. My Cipro experience, Rupert Murdoch made a defiant address to shareholders, describing the criticism of his company as "both understandable scrutiny and unfair attack."
As expected, there were shareholders who called for Murdoch and his sons to step down, and a good number of critical questions parried by Murdoch, as paidContent documented. But the main business of the meeting remained unaffected: Murdoch and his sons were re-elected to the News Corp, effects of Cipro. board, though there was speculation that an "embarrassingly high" number of shareholders voted against them, according to the Independent. Cipro Over The Counter, Meanwhile, former Dow Jones CEO Les Hinton testified before a committee of Parliament about the phone hacking and, predictably, gave a whole lot of "I don't recall"s and non-answers.
Reading roundup: This week was one of those weeks without many big stories in the future-of-journalism world, Purchase Cipro online no prescription, but with a lot of small ones. Here are a few of them:
— As Megan Garber reported at the Lab this week, USA Today tried something new that we may see other news organizations doing in the future, licensing the data from the databases it produces on its website to commercial app developers. As GigaOM's Mathew Ingram and the Knight Digital Media Center's Amy Gahran pointed out, the real benefit of moves like this may be less about revenue and more about a creating a crowdsourced R&D department, Cipro online cod.
— The death of former Libyan leader Moammar Gadhafi was the big news story late last week, and there were a couple of media-oriented angles. The big one was whether news orgs chose to show pictures or video of Gadhafi dead or being beaten, Cipro Over The Counter. Poynter's Julie Moos found that U.S. newspapers were less likely than European ones to run the gruesome images. Cipro forum, Those orgs that did run them ended up having to defend themselves. Meanwhile, Techdirt's Mike Masnick looked at the copyright issues involved with camera-phone footage of Gadhafi's beating. Cipro Over The Counter, — After Jeff Jarvis and Evgeny Morozov traded blows over the past couple of weeks about Jarvis' new book, "Private Parts," the Lab's Megan Garber weighed in with a brilliant post on why books's ideas aren't truly read and discussed, and how to make it so that they are. Jarvis chimed in with some more ways to disrupt the book/conference cycle.
— Gawker's Hamilton Nolan unearthed a sketchy linking-for-pay scheme from a small marketing company that claimed to have pulled it off with the Huffington Post and Business Insider. Those two orgs, buy Cipro online cod, naturally, issued denials.
— Media/tech entrepreneurs Cody Brown and Katie Ray introduced another venture this week with Scroll, a tool intended to help publishers use a variety of more sophisticated web designs without knowing how to code them. The Lab had a profile of it.
— In a masterful column, the New York Times' David Carr suggested that some of the Occupy Wall Street agitation should be directed toward newspaper chains, such as Gannett and the Tribune Co., who give their executives massive bonuses while laying off employees.
— Finally, I've linked to a lot of "programming for journalists" guides and tipsheets here, but this one by Jonathan Richards at the Guardian may be the best I've seen at capturing and explaining the coding mentality in simple terms. Give it a read.
Similar posts: Cephalexin Cost. Glucophage Mg. Retin A For Sale. Retin A mg. Discount Cipro. Buy Zoloft online cod.
Trackbacks from: Cipro Over The Counter. Cipro Over The Counter. Cipro Over The Counter. Cipro without prescription. Real brand Cipro online. Cipro dosage.
[This review was originally posted at the Nieman Journalism Lab Armour For Sale, on Jan. 28, 2011.]
Playing WikiLeaks Whack-a-Mole: Ever since WikiLeaks broke through into the public's consciousness last summer, observers have been predicting that its functions would be replicated by other organizations, both within and outside traditional journalism. We've seen signs of that for a couple of months, but the movement toward leakiness got a few big boosts this week with the launch of a leak submission system by Al Jazeera and the news that The New York Times is considering one of its own, Armour gel, ointment, cream, pill, spray, continuous-release, extended-release.
Al Jazeera started off with the release of the Palestine Papers, and the Palestinian Authority responded by blocking the new site. The Times' executive editor, Bill Keller, said his paper's looking at something along the lines of Al Jazeera's system, Cheap Armour, and a group from the CUNY Graduate School is also launching Localeaks, which allows leakers to submit leaks to any one of more than 1,400 local newspapers in the U.S. Meanwhile, WikiLeaks' Julian Assange told the Associated Press that he's up to 20 media partners and is hoping to triple that number in the next few months, Armour For Sale.
A couple of writers weighed in with thoughtful takes on these developments: Mathew Ingram of GigaOM suggested that leakers might still prefer WikiLeaks because it allows them freedom from relying on only one organization's view of the documents, since WikiLeaks works with numerous competing news outlets. In a particularly insightful piece, Raffa Khatchadourian of The New Yorker expounded on the strengths and weaknesses of the traditional media alternative to WikiLeaks, buy cheap Armour no rx, focusing on the two organizations' ties to societal conventions: "accountability limits the Times, but it also offers it protections—protections that WikiLeaks at the moment does not enjoy because, among other things, there is not enough public consensus on what it is and stands for."
That chasm between the culture of the Times and WikiLeaks was vividly manifested this week with the Times' publication of an essay by Keller about his paper's dealings with WikiLeaks, painting a less-than-flattering picture of Assange. Order Armour online overnight delivery no prescription, (The Daily Beast and Yahoo News have good summaries of the piece.) WikiLeaks denounced the article, and Gawker's John Cook found Keller's insults off-putting, especially given the service Assange has done his paper. Cook also pointed out the degree to which the Times worked with the U.S. Armour For Sale, State Department in releasing the cables, a practice that's probably quite at odds with Assange's theory of radical transparency.
Ongo's paid aggregation plan: Few topics are hotter in the future-of-news world than aggregation, except perhaps for the ongoing quest to find a way to make money off of news online. So when a startup combines both, Armour class, like Ongo is doing, people are going to pay attention. The service, launched this week by eBay/Skype/PayPal alum Alex Kazim, offers aggregated news from several major news outlets for fees starting at $6.99 a month. Armour from canada, Kazim told paidContent that he's targeting users who graze among numerous news sites and value a sharp user experience more highly than the content itself.
The instant reviews weren't exactly enthusiastic, Armour For Sale. Mashable's Lauren Indvik said that Ongo's slim selection of news outlets will likely leave users getting only a fraction of their daily news via Ongo — something they may not be willing to pay for. (Andrew Edgecliffe-Johnson of the Financial Times made a similar argument.) Zee Kane of The Next Web said Flipboard, Feedly and Google Reader all provide similar services, and they're all cheaper and better. Lost Remote's Cory Bergman compared Ongo with Hulu's model, but noted that Hulu's product (entertainment TV) is scarcer and more highly demanded than Ongo's product (online news), Armour mg.
GigaOM's Mathew Ingram had the harshest criticism, arguing that no one who knows how to use RSS will have any reason to use Ongo."Ongo seems like yet another Hail Mary pass aimed at trying to rewind the clock and impose scarcity on media content, and one that will likely fail just as quickly as others have," he wrote. Armour For Sale, But there is one group of people who have quite a bit of faith in Ongo — newspaper executives, particularly those from The New York Times, The Washington Post, and Gannett, all of whom have invested in the company. The Times, Armour pics, of course, is planning an online paid-content plan of its own, which The Wall Street Journal reported it will begin rolling out next month. According to the Journal, the Times' current plan has an iPad/web bundle costing more than twice as much as a website subscription alone, leading Reuters' Felix Salmon to wonder why the Times seems to be planning on pushing readers away from its iPad app.
Wall Street's warm welcome for Demand Media: Demand Media, cheap Armour no rx, the most prominent of the "content farms" that have drawn so much criticism over the past year or so, had an extraordinarily successful initial public offering on Wall Street this week, with first-day trading pushing its valuation to $1.5 billion Wednesday — higher than The New York Times Co. itself. That had to sting quite a bit for the Times, especially considering that, as Rafat Ali reported and The Wall Street Journal confirmed, the Times had almost bought Demand a few years back, Armour For Sale.
Demand's trading was driven by a lot of enthusiasm — exemplified by Keith Richman at Advertising Age — about the efficiency and profitability of its business model, Kjøpe Armour på nett, köpa Armour online, but its detractors are still loud, too. Forbes' Jeff Bercovici mocked some ridiculous Demand articles, and The Columbia Journalism Review's Lauren Kirchner told journalists why they should care: Demand is "a company that works every day to lower the standards of online content, that devalues the skills of reporting and writing, and that removes any incentive for original thought in exchange for quantity and speed."
Someone else who signaled its displeasure with companies like Demand this week: Google, on whom much of Demand's business model rests, Armour class. In a blog post, Google's Matt Cutts explained the shift in the company's antispam efforts toward a content-farm crackdown. Lauren Kirchner called spammers "tapeworms" for Google, but at Business Insider, Ben Elowitz argued that Google and Demand have a mutual (and mutually destructive) advertising-based relationship. Armour For Sale, Demand's Richard Rosenblatt, meanwhile, insisted that Cutts' post wasn't about Demand, and that the two companies have a healthy, "synergistic" relationship. Where can i buy cheapest Armour online, Search Engine Land's Danny Sullivan imagined what a Demand Media edition of The New York Times' website might look like, then urged news companies to both news coverage and "answers coverage" like the content farms — only a bit smarter.
Olbermann's exit: When MSNBC pundit Keith Olbermann ended his eight-year run hosting Countdown on Friday, it wasn't entirely unexpected — MSNBC suspended Olbermann in November for his contributions to Democratic candidates, touching off a simmering debate about objectivity and journalism. As The New York Times reported, Olbermann's exit was weeks in the making, Armour over the counter. Though its exact cause wasn't clear, Yahoo's Michael Calderone threw out a few possible reasons why Olbermann might have left.
In the wake of his departure, there was a bit of talk about Olbermann's place within the past decade of journalism: Lehigh j-prof Jeremy Littau said Olbermann's angry voice didn't fit the times anymore, though the Philadelphia Daily News' Will Bunch made a similar point in a more positive vein, suggesting Olbermann left because he had accomplished his mission giving voice to the appalled journalist and citizen, Armour For Sale. And Dave Winer urged Olbermann to now go directly to his audience, using the web to circumvent the traditional he just left.
Apple's subscription struggle: Apple's clampdown on publishers' hopes for subscriptions for the iPhone and iPad continues to ripple through the media world. Buy cheap Armour no rx, French analyst Frederic Filloux has a fantastic breakdown of the situation, explaining why publishers (especially smaller ones) are so upset and why they could take their app development elsewhere. ReadWriteWeb's Richard MacManus said the subscription plans would be good for consumers and publishers, but cautioned that it would put much of the business under Apple's control.
A few individual publishers' iPad developments: PaidContent gave us details of The Guardian's evolving plans Armour For Sale, for an iPad app, new publisher Nomad Editions launched four tablet-only magazines, and oh yeah, apparently Rupert Murdoch's coming out with some daily tablet-based news publication next week.
Reading roundup: A lot of big stories this week, so I'll go light on the ephemera:
— Last week's conversation (summarized nicely by David Cohn) about journalism education spilled over into this week. Tech pioneer Dave Winer provided this week's big idea with a great post on educating the "journo-programmer" (published in condensed form at the Lab), buy Armour online cod. Among his ideas: Teach aggregation, get away from the hackathon model, and just start doing it. PBS MediaShift profiled a innovative journalism program with which Winer is affiliated — Jay Rosen's Studio 20 at NYU.
— Your deep thought on the web for the week: Tech luminary John Battelle on the need for a new, revealed identity online.
— On the media literacy front, Paul Bradshaw, a j-prof at City University London and Birmingham City University, wrote a fantastic guide to verifying information online, focusing on content, context, and code.
— And in case you were wondering just what the heck is going on with the web right now, uh, The Oatmeal has you more than covered.
Similar posts: Synthroid Price. Order Tramadol. Retin A Cost. Retin A from mexico. Armour no prescription. Lipitor maximum dosage.
Trackbacks from: Armour For Sale. Armour For Sale. Armour For Sale. Armour schedule. Purchase Armour online. After Armour.
[This review was originally posted at the Nieman Journalism Lab Tramadol Over The Counter, on Jan. 7, 2011.]
A net neutrality compromise: The Review might have taken two weeks off for the holidays, but the rest of the future-of-news world kept on humming. Consider this more your "Holidays in Review" than your "Week in Review." Let's get to it.
The biggest news development of the past few weeks came just before Christmas, when the FCC passed a set of Internet regulations that were widely characterized as a compromise between net neutrality advocates and big Internet service providers. Tramadol pharmacy, In essence, the rules will keep ISPs from blocking or slowing services on the traditional wired Internet, but leave the future of wireless regulation more unclear. (Here's a copy of the order and a helpful explainer from GigaOM.)
In the political realm, the order drew predictable responses from both sides of the aisle: Conservatives (including at least one Republican FCC commissioner) were skeptical of a move toward net neutrality, while liberals (like Democratic Sen. Al Franken) fervently argued for it, Tramadol Over The Counter. In the media-tech world, it was greeted — as compromises usually are — with near-universal disdain. The Economist ran down the list of concerns for net neutrality proponents, led by the worry that the FCC "has handed the wireless carriers a free pass." This was especially troubling to j-prof Dan Kennedy, who argued that wireless networks will be far more important to the Internet's future than wired ones, Tramadol samples.
Salon's Dan Gillmor said the FCC paid lip service to net neutrality, paving the way for a future more like cable TV than the open web we have now. Newsweek's Dan Lyons compressed his problems with the order into one statement: "There will soon be a fast Internet for the rich and a slow Internet for the poor."
From the other side, Slate media critic Jack Shafer, a libertarian, questioned whether the FCC had the power to regulate the Internet at all, Order Tramadol no prescription, and imagined what the early Internet would have been like if the FCC had regulated it then. The Los Angeles Times' James Rainey told both sides Tramadol Over The Counter, to calm down, and at the Knight Digital Media Center, Amy Gahran used the story as an object lesson for news organizations in getting and linking to the source documents in question.
WikiLeaks and the media's awkward dance: The long tail of this fall's WikiLeaks story continues to run on, meandering into several different areas over the holidays. There are, of course, ongoing efforts to silence WikiLeaks, both corporate (Apple pulled the WikiLeaks app from its store) and governmental (a bill to punish circulation of similar classified information was introduced, and criticized by law prof Geoffrey Stone), online buying Tramadol.
In addition, Vanity Fair published a long piece examining the relationship between WikiLeaks' Julian Assange and The Guardian, the first newspaper to partner with him. Based on the story, Slate's Jack Shafer marveled at Assange's shrewdness and gamesmanship ("unequaled in the history of journalism"), Reuters' Felix Salmon questioned Assange's mental health, Buy cheap Tramadol, and The Atlantic's Nicholas Jackson wondered why The Guardian still seems to be playing by Assange's rules.
We also saw the blowup of Salon columnist Glenn Greenwald's feud with Wired over some chat logs between alleged WikiLeaks leaker Bradley Manning and the man who turned him in, Tramadol Over The Counter. It's a complicated fight I'm not going to delve into here, but if you'd like to know more, here are two good blow-by-blows, one more partial to Wired, and another more sympathetic to Greenwald.
Greenwald has also continued to be one of the people leading the inquiries into the traditional media's lack of support for WikiLeaks. Alternet rebutted several media misconceptions about WikiLeaks, rx free Tramadol, and Newsweek attempted to explain why the American press is so lukewarm on WikiLeaks — they aren't into advocacy, and they don't like Assange's purpose or methods. One of the central questions to that media cold-shoulder might be whether Assange is considered a journalist, something GigaOM's Mathew Ingram tried to tackle. Tramadol Over The Counter, Other, more open critiques of WikiLeaks continue to trickle out, including ones from author Jaron Lanier and Floyd Abrams, a lawyer who argued for The New York Times in the Pentagon Papers case. Abrams' argument prompted rebuttals from Jack Shafer and NYU prof Clay Shirky. Shirky in particular offered a nuanced comparison of the Pentagon Papers-era Times and the globally oriented WikiLeaks, concluding that "the old rules will not produce the old outcomes." If you're still hungry for WikiLeaks analysis, Tramadol trusted pharmacy reviews, John Bracken's rounded up the best of the year here.
Looking back, and looking forward: We rang in the new year last week, and that, of course, always means two things in the media world: year-end retrospectives, and previews of the year to come. The Lab wrapped up its own year in review/preview before Christmas with a review of Martin Langeveld's predictions for 2010. PBS' MediaShift also put together a good set of year-end reviews, order Tramadol online c.o.d, including ones on self-publishing, the rapidly shifting magazine industry, a top-ten list of media stories (led by WikiLeaks, Facebook, and the iPad). You can also get a pretty good snapshot of the media year that was by taking a look at AOL's list of the top tech writing of 2010.
Poynter's Rick Edmonds examined the year in newspaper stock prices (not great, but could've been worse), while media consultant Alan Mutter explained that investors tended to stay away from debt-laden newspaper companies in particular, Tramadol Over The Counter. Get Tramadol, As for the year to come, the Lab's readers weighed in — you like ProPublica, The Huffington Post, and Clay Shirky, and you're split on paywalls — and several others chimed in with their predictions, too. Among the more interesting prognostications: New York Times media critic David Carr sees tablets accelerating our ongoing media convergence, The Next Web forecasts a lot of blogs making the Gawker-esque beyond the blog format, online buy Tramadol without a prescription, Mashable's Vadim Lavrusik predicts the death of the foreign correspondent, TBD's Steve Buttry sees many journalism trade organizations merging, and the Lab's Martin Langeveld thinks we'll see John Paton's innovative measures at the Journal Register Co. slowly begin to be emulated elsewhere in the newspaper industry.
Two other folks went outside the predictions mold for their 2011 previews: media analyst Ken Doctor looked at 11 pieces of conventional wisdom the media industry will test this year, and the University of Colorado's Steve Outing outlined his wishes for the new year. Tramadol Over The Counter, Specifically, he wants to see News Corp. My Tramadol experience, and The New York Times' paid-content plans fail, and to see news execs try a value-added membership model instead. "This will require that news publishers actually work their butts off to sell, rather than sit back and expect people to fork over money "just because" everyone should support journalism," he wrote.
Rethinking publishing for the tablet: One theme for the new year in media that's already emerged is the impending dominance of the tablet. As The New York Times' Joshua Brustein wrote, that was supposed to be the theme last year, too, Tramadol recreational, but only the iPad was the only device able to get off the ground in any meaningful way. Several of Apple's competitors are gearing up to make their push this year instead; The Times' Nick Bilton predicted that companies that try to one-up Apple with bells and whistles will fail, though Google may come up with a legitimate iPad rival.
Google has begun work toward that end, looking for support from publishers to develop a newsstand to compete with Apple's app store, Tramadol Over The Counter. And Amazon's Kindle is doing fine despite the iPad's popularity, TechCrunch argued. Meanwhile, Tramadol from mexico, Women's Wear Daily reported that magazine app sales on the iPad are down from earlier in the year, though Mashable's Lauren Indvik argued that the numbers aren't as bad as they seem.
The magazine numbers prompted quite a bit of analysis of what's gone wrong with magazine apps. British entrepreneur Andrew Walkingshaw ripped news organizations for a lack of innovation in their tablet editions — "tablets are always-on, tactile, completely reconfigurable, great-looking, permanently jacked into the Internet plumbing, Tramadol results, and you’re using them to make skeumorphic newspaper clones?" — and French media consultant Frederic Filloux made similar points, urging publishers to come up with new design concepts and develop a coherent pricing structure (something Econsultancy's Patricio Robles had a problem with, too). Tramadol Over The Counter, There were plenty of other suggestions for tablet publications, too: GigaOM's Mathew Ingram said they should focus on filtering the web, MG Siegler of TechCrunch asked for an easy-to-use newsstand rather than a system of standalone apps, and Alan Mutter suggested magazines lower the prices and cut down on the technical glitches.
Three others focused specifically on the tablet publishing business model: At the Lab, Ken Doctor gave us three big numbers to watch in determining where this is headed, entrepreneur Bradford Cross proposed a more ad-based model revolving around connections to the open web, After Tramadol, and venture capitalist Fred Wilson predicted that the mobile economy will soon begin looking more like the web economy.
Reading roundup: A few items worth taking a look at over the weekend:
— The flare-up du jour in the tech world is over RSS, and specifically, whether or not it is indeed still alive. Web designer Kroc Camen suggested it might be dying, TechCrunch's MG Siegler fingered Twitter and Facebook as the cause, Dave Winer (who helped develop RSS) took umbrage, and GigaOM's Mathew Ingram and The Guardian's Martin Belam defended RSS' relevance.
— Add the Dallas Morning News to the list of paywalled (or soon-to-be-paywalled) papers to watch: It announced it will launch a paid-content plan Feb. 15, Tramadol Over The Counter. The Lab's Justin Ellis shed light on Morning News' thinking behind the plan. PaidContent's Staci Kramer alsobroke down a Pew report on paying for online content.
— For the many writers are considering how to balance social media and longer-form writing, two thoughtful pieces to take a look at: Wired's Clive Thompson on the way tweets and texts can work in concert in-depth analysis, and Anil Dash on the importance of blogging good ideas.
— Finally, NPR's Matt Thompson put together 10 fantastic lessons for the future of media, all coming from women who putting them into action. It's an encouraging, inspiring set of insights.
Similar posts: Purchase Cephalexin. Order Glucophage. Lipitor Price. Low dose Zoloft. Lipitor duration. Zoloft pictures.
Trackbacks from: Tramadol Over The Counter. Tramadol Over The Counter. Tramadol Over The Counter. Tramadol natural. Tramadol pharmacy. Tramadol no rx.